Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Consulting agrmnt
Director departure
Quarterly results
|
|
APPLIED DNA SCIENCES INC (APDN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/12/2019 |
8-K
| Entered into consulting agreement|
Docs:
|
"Asset Purchase Agreement, by and between LineaRX, Inc. and Vitatex Inc",
"Forward-Looking Statements The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’ s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to the risk that the acquisition will not be successfully integrated with LineaRx or that the potential benefits of the acquisition will not be realized, the Company’ s history of net losses, limited financial resources, limited market acceptance , the uncertainties inherent in research and development, futur..." |
|
| 09/17/2015 |
8-K
| Form 8-K - Current report |
| 07/16/2010 |
8-K
| Form 8-K - Current report |
| 07/21/2005 |
8-K
| Form 8-K - Current report |
|
|